Table 2 Baseline characteristics of the population according to the cut-off value of PNI
Variables | Group 1 (n = 545) | Group 2 (n = 635) | p-value |
|---|---|---|---|
Demographics | |||
 Age (years) | 70 (61.00–78.00) | 67.00 (58.00–74.00) | < 0.001 |
 Male, n (%) | 336 (61.65) | 445 (70.08) | 0.002 |
 SBP (mmHg) | 110.97 (103.67-120.55) | 112.13 (106.30-119.31) | 0.061 |
 DBP (mmHg) | 59.30 (54.07–66.82) | 59.53 (53.64–65.54) | 0.828 |
 CCU, n (%) | 254 (46.61) | 550 (86.61) | < 0.001 |
Risk factors, n (%) | |||
 Hypertension | 124 (22.75) | 272 (42.83) | < 0.001 |
 AF | 253 (46.42) | 228 (35.91) | < 0.001 |
 CHF | 324 (59.45) | 234 (36.85) | < 0.001 |
 CKD | 239 (43.85) | 160 (25.20) | < 0.001 |
 Non-STEMI | 456 (83.67) | 532 (83.78) | 0.959 |
 DM | 246 (45.14) | 297 (46.77) | 0.574 |
Biochemical parameters | |||
 HB (g/dL) | 10.20 (8.70–11.90) | 12.70 (11.10–14.10) | < 0.001 |
 Bicarbonate (mmol/L) | 22.00 (20.00–25.00) | 24.00 (22.00–26.00) | < 0.001 |
 CR (mg/dL) | 1.70 (1.20–3.10) | 1.10 (0.80–1.40) | < 0.001 |
 Potassium (mmol/L) | 4.70 (4.20–5.30) | 4.60 (4.40-5.00) | 0.912 |
 PT (s) | 15.30 (13.30-18.95) | 15.10 (13.40–17.00) | 0.028 |
Cardiovascular medications, n (%) | |||
 Antiplatelet drugs | 472 (86.61) | 615 (96.85) | < 0.001 |
 β-blockers | 400 (73.39) | 586 (92.28) | < 0.001 |
 ACEI/ARB | 174 (31.93) | 311 (48.98) | < 0.001 |
 Statins | 454 (83.30) | 607 (95.59) | < 0.001 |
Score system | |||
 SOFA score | 8.00 (6.00–12.00) | 6.00 (4.00–8.00) | < 0.001 |
 CCI | 8.00 (6.00–10.00) | 6.00 (5.00–8.00) | < 0.001 |
Outcome | |||
 ICU LOS (days) | 4.10 (2.36–7.37) | 2.22 (1.35–3.85) | < 0.001 |
All-cause-mortality, n (%) | |||
 In-hospital mortality | 136 (24.95) | 44 (6.93) | < 0.001 |
 6-month mortality | 160 (29.36) | 50 (7.87) | < 0.001 |
 1-year mortality | 167 (30.64) | 50 (7.87) | < 0.001 |